This systematic review and meta-analysis looked at how well liposomal iron works compared to conventional oral iron for treating iron deficiency anemia in children. The study combined data from 454 pediatric patients to compare the two treatments over a six-month period. Researchers found that children taking liposomal iron had a significantly greater increase in hemoglobin levels than those taking conventional iron. They also saw improvements in other blood markers like mean corpuscular hemoglobin and total iron-binding capacity.
Safety was another key focus of the research. The analysis showed that liposomal iron was associated with fewer adverse events overall. Specifically, the risk of constipation was lower for children using the liposomal form. The data suggests better tolerability for this specific type of iron supplement in this age group.
However, the evidence remains preliminary. The study noted substantial differences between the results of the included trials. Experts say larger randomized controlled trials are needed to confirm these findings before changing standard practice. Until more data is available, doctors should consider these results as promising but not yet definitive proof.
